We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

New Malaria Monoclonal Antibodies

Read time: Less than a minute

Malaria is a mosquito-borne parasitic infection caused by several species of Plasmodium. It is prevalent world wide in subtropical regions of Africa, Asia and the Americas.

Symptoms include fever and headache but can proceed to coma and death.

The majority of deaths are caused by P. falciparum. During the blood stage infection, P. falciparum secretes large quantities of a glycoprotein termed Histidine- Rich Protein II (HRP II). Detection of HRP II in serum or plasma correlates to active parasitemia.

ViroStat has released a new set of monoclonal antibodies to the HRP II protein of P. falciparum. These antibodies should be useful to researchers and those needing to develop rapid tests for this protein.

Google News Preferred Source Add Technology Networks as a preferred Google source to see more of our trusted coverage.